3PC-039 Centralised non-hazardous intravenous compounding: improvement of clinical practice

BACKGROUND: In April 2016 the Central IntraVenous Additive Service (CIVAS) began to compound non-toxic injectable therapies with a robotic system.(1) The production started with antiemetic therapies, followed by antibiotic therapies ready to infuse, as cefazoline 1 g in syringes and piperacillin-taz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Celestino, S, Leoni, S, Guglielmi, S, Moriconi, L, Marinozzi, A, Polidori, C, Paolucci, D, Bufarini, C
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 3: Production and compounding
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535527/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.91
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados